Loading
Latest filing published 17 Sept 2026 for BioStem Technologies, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Only one filing by Kenneth Howard Warrington Jr. is known so far (17 September 2026): an option exercise, in BioStem Technologies, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration